LB Pharmaceuticals’ public listing comes amid a dry spell for biotech IPOs despite a flurry of activity early in 2025.

In this interview, Charles Chase, PhD, the VP and Technical Business Development at Asymchem, a technology-focused pharmaceutical manufacturing company, discusses the significant impact of RNA ...

SkyQuest Technology Consulting published a report, titled, 'Biotechnology Market - Global Opportunity Analysis and Industry Forecast, 2025-2032', valued at $2.16 Trillion in 2024. With a projected ...

Insitro, Firefly Bio and Superluminal Medicines are among the first participants in Lilly’s “TuneLabs” platform, which the ...

The incredible success of the two mRNA vaccines against COVID-19 sparked a surge of interest and investment in this new therapeutic modality. And because mRNA is infinitely programmable, scientists ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small ...

Technology Ltd. ( (HK:0660) ) has provided an update. Wai Chun Bio-Technology Limited has announced a revised timetable for ...

While the economic future is still murky, easing interest rates and cooling inflation means that biotech companies could be primed for a bounce-back 2023, The Wall Street Journal reported Jan. 17. The ...

Stefan Ries joins as CSO, bringing more than two decades of drug development experience in the pharmaceutical industry complemented by a background in venture capital ...

Roye, 59, is one of Long Island’s best-known technology gurus, having started Invision.com in 1995. It was one of the few Long Island internet companies to have survived the dot-com bust of the early ...